Detalhe da pesquisa
1.
Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial.
Lancet Oncol
; 18(6): 755-769, 2017 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28479233
2.
Effect of patient age on management decisions in breast cancer: consensus from a national consultation.
Oncologist
; 15(7): 657-64, 2010.
Artigo
Inglês
| MEDLINE | ID: mdl-20551430
3.
Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group study.
Breast Cancer Res Treat
; 122(3): 787-94, 2010 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-20559708
4.
Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer.
N Engl J Med
; 355(18): 1851-62, 2006 Nov 02.
Artigo
Inglês
| MEDLINE | ID: mdl-17079759
5.
Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data.
J Clin Oncol
; 36(19): 1981-1990, 2018 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29718793
6.
Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study.
J Clin Oncol
; 23(13): 2988-95, 2005 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-15860854
7.
High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials.
J Clin Oncol
; 29(24): 3214-23, 2011 Aug 20.
Artigo
Inglês
| MEDLINE | ID: mdl-21768471
8.
What is the impact of antithrombotic therapy and risk factors on the frequency of thrombovascular events in patients with metastatic breast cancer receiving epoetin beta?
Eur J Cancer
; 45(17): 2984-91, 2009 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-19646862
9.
Pegfilgrastim; a neutrophil mediated granulocyte colony stimulating factor-expanding uses in cancer chemotherapy.
Expert Opin Biol Ther
; 8(7): 993-1001, 2008 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-18549328
10.
Capecitabine and docetaxel combination for the treatment of breast cancer.
Womens Health (Lond)
; 4: 11-22, 2008 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-19072447
11.
Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.
J Clin Oncol
; 26(4): 592-8, 2008 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-18235117
12.
The in vitro anti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancer.
Acta Oncol
; 46(5): 669-77, 2007.
Artigo
Inglês
| MEDLINE | ID: mdl-17562444
13.
Maintenance hormone therapy with letrozole after first-line chemotherapy for advanced breast cancer.
Oncology
; 68(4-6): 364-70, 2005.
Artigo
Inglês
| MEDLINE | ID: mdl-16020964
14.
Sequential treatment with exemestane and non-steroidal aromatase inhibitors in advanced breast cancer.
Oncology
; 69(6): 471-7, 2005.
Artigo
Inglês
| MEDLINE | ID: mdl-16410685
15.
Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
J Natl Cancer Inst
; 96(14): 1076-83, 2004 Jul 21.
Artigo
Inglês
| MEDLINE | ID: mdl-15265969